Methyl 3-(3-bromo-1H-pyrazol-1-yl)propanoate

Catalog No. :
ACKMOT364
CAS No. :
1855890-47-9
Molecular Formula :
C7H9BrN2O2
Molecular Weight :
233.07

IUPAC Name:methyl 3-(3-bromo-1H-pyrazol-1-yl)propanoate

Methyl 3-(3-bromo-1H-pyrazol-1-yl)propanoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$358.00Login to see priceIn stockInquiry
250mg98%$715.00Login to see priceInquiryInquiry
1g98%$1023.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 3-(3-bromo-1H-pyrazol-1-yl)propanoate
IUPAC Namemethyl 3-(3-bromo-1H-pyrazol-1-yl)propanoate
MDL No.MFCD29060584
Molecular FormulaC7H9BrN2O2
Molecular Weight233.07
SMILESO=C(OC)CCN1N=C(Br)C=C1
InChI KeyXXNNZCYFXWMFQI-UHFFFAOYSA-N
Synonymmethyl 3-(3-bromo-1H-pyrazol-1-yl)propanoate;1H-Pyrazole-1-propanoic acid, 3-bromo-, methyl ester;ethyl 3-(3-bromo-1H-pyrazol-1-yl)propanoate
CAS No.1855890-47-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACKMOT364 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCZYN563 route compound structure diagram
    ACCZYN56314521-80-3 In Stock
  2. Plus
  3. ACBQME651 route compound structure diagram
    ACBQME6513395-91-3 In Stock
  4. Then
  5. ACKMOT364 route product structure diagram
    ACKMOT3641855890-47-9 In Stock
Inquiry

2. ACKMOT364 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCZYN563 route compound structure diagram
    ACCZYN56314521-80-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKMOT364 route product structure diagram
    ACKMOT3641855890-47-9 In Stock
Inquiry

Comments (0)